<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> and either the 3q21q26 syndrome or t(1;3)(p36;q21) have been reported to share similar clinicopathological features and a common molecular mechanism for <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Overexpression of MDS1/EVI1 (3q26) or MEL1/PRDM16 (1p36), both members of the PR-domain family, has been directly implicated in the <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of this subset of <z:hpo ids='HP_0002664'>neoplasias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The breakpoints in both entities are outside the genes, and the 3q21 region, where RPN1 is located, seems to act as an enhancer </plain></SENT>
<SENT sid="3" pm="."><plain>MEL1 has been reported to be expressed in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells with t(1;3) and in the <z:mpath ids='MPATH_458'>normal</z:mpath> uterus and fetal kidney, but neither in bone marrow (BM) nor in other tissues, suggesting that this gene is specific to t(1;3)-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We report the molecular characterization of a t(1;3)(p36;q21) in a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:e sem="disease" ids="C1318551" disease_type="Neoplastic Process" abbrv="">RAEB-2</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast to previous studies, we demonstrate that MEL1, the PR-containing form, and MEL1S, the PR-lacking form, are widely expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues, including BM </plain></SENT>
<SENT sid="6" pm="."><plain>The clinicopathological features and the breakpoint on 1p36 are different from cases previously described, and MEL1 is not overexpressed, suggesting a <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in myeloid <z:hpo ids='HP_0002664'>neoplasias</z:hpo> with t(1;3) </plain></SENT>
</text></document>